4D Pharma plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by David Norwood, was filed 18 Mar 2020.
4D Pharma plc: what insiders have been doing
Every trade that managers of 4D Pharma plc disclose to RNS (LSE) is tracked on this page. 4D Pharma plc has had no insider filing for more than a year; the last one goes back to 18 March 2020.
Since 2018, the database holds 10 purchases and no sales by insiders of the company.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
- 100,000 shares@ £0.28100.0% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20200318074912_3531206_20200402164404231Canonical exit: 16 Jun 2020 (T+90)
- 15,000 shares@ £1.0018.9% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190530070008_14091626_20200326185141071_3017Canonical exit: 28 Aug 2019 (T+90)
- 9,891 shares@ £1.056.5% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190523070009_14084402_20200326185141958_9509Canonical exit: 21 Aug 2019 (T+90)
- 5,000 shares@ £0.966.1% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190522070006_14082715_20200326185142053_11038-0Canonical exit: 20 Aug 2019 (T+90)
- 152,197 shares@ £0.9893.5% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190522070006_14082715_20200326185142053_11038-1Canonical exit: 20 Aug 2019 (T+90)
- 31,666 shares@ £0.91515.8% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190314070020_14001563_20200326185133974_17152Canonical exit: 12 Jun 2019 (T+90)
- 4,800 shares@ £0.85100.0% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190313090801_14000449_20200326185134023_18179-1Canonical exit: 11 Jun 2019 (T+90)
- 23,725 shares@ £0.823620.1% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190313090801_14000449_20200326185134023_18179-0Canonical exit: 11 Jun 2019 (T+90)
- 10,000 shares@ £1.0312.7% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20181221070003_13912391_20200330111409229_20357Canonical exit: 21 Mar 2019 (T+90)
- 20,000 shares@ £1.1428.2% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20181219070004_13908850_20200330111409092_17501Canonical exit: 19 Mar 2019 (T+90)
10 of 10 declarations
About 4D Pharma plc
4D Pharma plc is a biopharmaceutical company focused on developing treatments based on the microbiome. It is listed on the London Stock Exchange.
